close search

Evaluating cost-effective investments to reduce the burden of drug-resistant tuberculosis (TB) in Kyrgyz Republic

Document outline

This report outlines recommendations to minimise both drug-resistant tuberculosis (TB) cases and TB-related deaths in Kyrgyzstan by 2030. It describes the Optima TB model used to carry out analyses.

Read the report (PDF 2 MB)